Ionic and cellular mechanisms underlying the development of acquired Brugada syndrome in patients treated with antidepressants. - Wikidata - awgldk - TriplyDB

Ionic and cellular mechanisms underlying the development of acquired Brugada syndrome in patients treated with antidepressants.

Ionic and cellular mechanisms underlying the development of acquired Brugada syndrome in patients treated with antidepressants.

http://www.wikidata.org/entity/Q36310359

about

J-wave syndromes: Brugada and early repolarization syndromes Effect of Wenxin Keli and quinidine to suppress arrhythmogenesis in an experimental model of Brugada syndrome.J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge Drug-induced QT-interval shortening following antiepileptic treatment with oral rufinamide.Brugada Syndrome: Clinical, Genetic, Molecular, Cellular, and Ionic Aspects.Novel Therapeutic Strategies for the Management of Ventricular Arrhythmias Associated with the Brugada Syndrome Drug-induced Brugada syndrome by noncardiac agents.Psychotropic drug-associated electrocardiographic presentation of diffuse J-waves in hypothermia: case report and literature review.Sudden cardiac arrest associated with use of a non-cardiac drug that reduces cardiac excitability: evidence from bench, bedside, and community.The role of adenosine receptors on amitriptyline-induced electrophysiological changes on rat atrium.Amitriptyline is efficacious in ameliorating muscle inflammation and depressive symptoms in the mdx mouse model of Duchenne muscular dystrophy.Amitriptyline May Have Possibility to Induce Brugada Syndrome Rather than Long QT Syndrome.J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.Key Role of the Membrane Trafficking of Nav1.5 Channel Protein in Antidepressant-Induced Brugada Syndrome Mechanisms Underlying the Actions of Antidepressant and Antipsychotic Drugs That Cause Sudden Cardiac Arrest

P2860

Q26859366-58A270CC-DB1D-4AB1-BA53-CEB2C0D6984A Q30541203-9DAA1717-A606-46DC-9E85-2162DAAFA624 Q34534329-9C7EF6CE-EF23-427F-B684-0E1EC3B58FE7 Q36351042-9C44A68C-F921-4A39-8F45-9957BEF6BED1 Q36534132-C127270B-AF71-4077-AB26-3CFA284AD8D1 Q37194514-CE6FE350-A599-4FDA-9254-638211B89757 Q38132928-E7ADBBCF-921A-47A0-8192-6FB59C66844F Q38350113-88DA8DC9-C95D-42C9-AAAF-F6D3C98991FA Q44543326-2E7F7B68-78CF-48BF-B2D1-7242C4EBB839 Q46613388-356ED80B-D006-4A7B-AFB5-79CD556B1238 Q48265187-907FE30C-5CED-46EE-B692-728A6D804388 Q53736482-6AA50CBD-E7A5-4012-A040-E38ACD1CF501 Q55059903-89C96042-A352-4A49-9AE5-492E0E304292 Q58762840-D25E2893-4D67-4204-8CE1-B9ED5EA3F03C Q58804311-D65170E6-9E2A-4C67-9FDF-475EFE096308

P2860

Ionic and cellular mechanisms underlying the development of acquired Brugada syndrome in patients treated with antidepressants.

http://www.wikidata.org/entity/Q36310359

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Ionic and cellular mechanisms ...... treated with antidepressants.

@ast

Ionic and cellular mechanisms ...... treated with antidepressants.

@en

type

label

Ionic and cellular mechanisms ...... treated with antidepressants.

@ast

Ionic and cellular mechanisms ...... treated with antidepressants.

@en

prefLabel

Ionic and cellular mechanisms ...... treated with antidepressants.

@ast

Ionic and cellular mechanisms ...... treated with antidepressants.

@en

P1433

Q36310359-8E4571C8-A7B5-421F-BFB4-4FC382EAFD73

P1476

Q36310359-164C91FC-A227-469A-9658-E55F6FEA9779

P2093

Q36310359-512BAD12-EE6D-4C65-98ED-968E2C45782D

Q36310359-56AEA12D-A485-4D8C-8CEF-EF0E0C24DDE8

Q36310359-74083F93-85A5-438D-A0E0-1F4FD1581BA8

Q36310359-CE1A3F41-618C-4AF5-AB76-E4F5EE856C9C

Q36310359-E0F33917-DFD2-498A-AF4A-0C1508FF2BF0

P2860

Q36310359-01C88B44-D8CC-4628-BC97-7F62A99C9595

Q36310359-0A3D4007-ECD8-4AF4-991D-8B9359608C5D

Q36310359-1B7EB250-A654-42BC-B7F8-324B4C33CF27

Q36310359-1BA2375D-86CD-4FD9-82DC-141E4C2C780A

Q36310359-1C62CF67-2D38-4527-B3AE-92D05102CC81

Q36310359-249E2E92-6EB8-4A1B-97C7-9624721E0D18

Q36310359-315A9EAE-D390-485F-9B59-BABA912FF8C1

Q36310359-32089F69-4FBF-4EA3-BEAE-A49CE9CDDE5C

Q36310359-3859C1BF-8DCB-468A-8128-F09C454ADD79

Q36310359-3F113C00-7C43-4A2B-A3AE-63345C60A309

P304

Q36310359-483F6C39-43A5-4E58-B651-CC4F208C5436

P31

Q36310359-8610D984-B72F-4597-8D81-ECE68BBE4F5D

P356

Q36310359-BB8126FD-7513-42F4-AD43-4AA992387E05

P433

Q36310359-C6964395-9B75-417F-B69B-8494275C1CDB

P478

Q36310359-E3CDC5B9-C520-45BA-9738-0BD907550BD3

P50

Q36310359-8AC9FA4C-EAD2-4BD5-AE7B-F5444875EF90

Q36310359-E890C63E-19CD-4662-80AA-B92B30C73EED

Q36310359-EEE09A19-1009-435A-9253-58E5E5259856

P577

Q36310359-75C35B24-AB93-4759-929E-2672C3BA09BF

P5875

Q36310359-2E1B0FD3-C410-47A6-9CE6-837758141E9F

P698

Q36310359-0AB0401F-CB3C-4A2E-943B-F39E3BD2680B

P932

Q36310359-24756B06-C2FB-433F-A2F8-49F3EA9C1420

P356

J.1540-8167.2011.02196.X

P1433

Journal of Cardiovascular Electrophysiology

P1476

Ionic and cellular mechanisms ...... s treated with antidepressants

@en

P2093

Andrew C Zygmunt

http://www.w3.org/2001/XMLSchema#string

Hector Barajas-Martínez

http://www.w3.org/2001/XMLSchema#string

José M Di Diego

http://www.w3.org/2001/XMLSchema#string

Serge Sicouri

http://www.w3.org/2001/XMLSchema#string

Yoshino Minoura

http://www.w3.org/2001/XMLSchema#string

P2860

Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias

Sodium channel β1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans

Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome

Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death

Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome

Gain-of-function mutation S422L in the KCNJ8-encoded cardiac K(ATP) channel Kir6.1 as a pathogenic substrate for J-wave syndromes

Genetic basis and molecular mechanism for idiopathic ventricular fibrillation

Transient ST segment elevation in right precordial leads induced by psychotropic drugs: relationship to the Brugada syndrome.

SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome.

A mutation in the beta 3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype

P304

423-432

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1540-8167.2011.02196.X

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

Charles Antzelevitch

P577

2011-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51754371

http://www.w3.org/2001/XMLSchema#string

P698

22034916

http://www.w3.org/2001/XMLSchema#string

P932

3468832

http://www.w3.org/2001/XMLSchema#string